Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

The purpose of the study is to determine whether T900607-sodium is effective and safe in treating hepatocellular carcinoma, a type of liver cancer.

Phase 2

Tularik